Liabilities and Equity in USD of Biofrontera Inc. from Q4 2020 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary: Biofrontera Inc. quarterly Liabilities and Equity history and change rate from Q4 2020 to Q3 2025.
Biofrontera Inc. Liabilities and Equity for the quarter ending 30 Sep 2025 was $15.4M, a 16.7% decline year-over-year.

Liabilities and Equity, Quarterly (USD)

Liabilities and Equity, YoY Quarterly Change (%)

Biofrontera Inc. Quarterly Liabilities and Equity (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$15.4M	-$3.1M	-16.7%	30 Sep 2025	10-Q	12 Nov 2025
Q2 2025	$20.1M	-$1.43M	-6.64%	30 Jun 2025	10-Q	13 Aug 2025
Q1 2025	$16.6M	-$7.99M	-32.5%	31 Mar 2025	10-Q	15 May 2025
Q4 2024	$22.1M	-$5.83M	-20.9%	31 Dec 2024	10-Q	12 Nov 2025
Q3 2024	$18.5M	-$15.6M	-45.7%	30 Sep 2024	10-Q	14 Nov 2024
Q2 2024	$21.6M	-$15.3M	-41.5%	30 Jun 2024	10-Q	14 Aug 2024
Q1 2024	$24.6M	-$17.4M	-41.4%	31 Mar 2024	10-Q	15 May 2024
Q4 2023	$27.9M	-$23M	-45.1%	31 Dec 2023	10-K	20 Mar 2025
Q3 2023	$34.1M	-$21M	-38.1%	30 Sep 2023	10-Q	09 Nov 2023
Q2 2023	$36.9M	-$16.7M	-31.2%	30 Jun 2023	10-Q	11 Aug 2023
Q1 2023	$42M	-$7.24M	-14.7%	31 Mar 2023	10-Q	12 May 2023
Q4 2022	$50.9M	-$2.34M	-4.39%	31 Dec 2022	10-K	15 Mar 2024
Q3 2022	$55.1M	+$39.7M	+259%	30 Sep 2022	10-Q	14 Nov 2022
Q2 2022	$53.6M			30 Jun 2022	10-Q	12 Aug 2022
Q1 2022	$49.2M			31 Mar 2022	10-Q	13 May 2022
Q4 2021	$53.2M	+$29.1M	+120%	31 Dec 2021	8-K	03 Oct 2023
Q3 2021	$15.4M			30 Sep 2021	10-Q	30 Nov 2021
Q4 2020	$24.1M			31 Dec 2020	10-K	11 Apr 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.